SCHEMBL28517406

SCHEMBL28517406

OCc1nc2c(Cl)c(-c3ccccc3F)c(Cl)cc2[nH]1

nearest known ligand 0.46

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ RHEB Q15382 10/20 0.46
▸ DHODH Q02127 5/20 0.43
▸ TDP1 Q9NUW8 1/20 0.39
▸ PRKAG1 P54619 1/20 0.36
▸ PRKAA2 P54646 1/20 0.36
▸ PRKAB1 Q9Y478 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30116420 1.00 RHEB (0.46) RHEBDHODHTDP1PRKAG1PRKAA2
SCHEMBL28511997 0.88 RHEB (0.48) RHEBTDP1PRKAG1PRKAA2PRKAB1
SCHEMBL30116444 0.88 RHEB (0.48) RHEBTDP1PRKAG1PRKAA2PRKAB1
SCHEMBL28508944 0.84 TRPA1 (0.44) RHEBTDP1
SCHEMBL30116523 0.84 TRPA1 (0.44) RHEBTDP1
SCHEMBL30116414 0.82 RHEB (0.53) RHEB
SCHEMBL28508959 0.82 RHEB (0.44) RHEBTDP1PRKAG1PRKAA2PRKAB1
SCHEMBL28517848 0.82 RHEB (0.53) RHEB
SCHEMBL23000280 0.72 SCD (0.43) DHODH
SCHEMBL28510942 0.71 DHODH (0.34) DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116514722-A Benzimidazole derivatives as modulators of retinoic acid related orphan receptor gamma (ROR gamma) and pharmaceutical uses thereof 江苏恒瑞医药股份有限公司 2023-08-01 — — CN disclosed
CN-112135611-B Benzimidazole derivatives as modulators of retinoic acid-related orphan receptor gamma (ROR γ) and pharmaceutical uses thereof 江苏恒瑞医药股份有限公司 2023-01-31 — — CN disclosed
CN-112135611-A Benzimidazole derivatives as modulators of retinoic acid-related orphan receptor gamma (ROR γ) and pharmaceutical uses thereof 江苏恒瑞医药股份有限公司 2020-12-25 — — CN disclosed
Send feedback